{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:47:09Z","timestamp":1761155229065},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1007\/bf02904687","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T23:14:40Z","timestamp":1231542880000},"page":"3-7","source":"Crossref","is-referenced-by-count":21,"title":["The complexity of the Epstein-Barr virus infection in humans"],"prefix":"10.1007","volume":"4","author":[{"given":"Eva","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02904687_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199509059657","volume":"19","author":"I Anagnostopoulos","year":"1995","unstructured":"Anagnostopoulos I, Hummel M and Stein H: Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review. Leuk Lymphoma 19:1\u201312, 1995.","journal-title":"A review. Leuk Lymphoma"},{"key":"BF02904687_CR2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood.V87.3.1045.bloodjournal8731045","volume":"87","author":"F Amore d","year":"1996","unstructured":"d Amore F, Johansen P, Houmand A, et al: Epstein-Barr virus genome in non-Hodgkin\u2019s lymphoma occurring in immunocompetent patients: Highest prevalence in non-lymphopblastic T-cell lymphoma and correlation with poor prognosis. Blood 87:1045\u20131055, 1996.","journal-title":"Blood"},{"key":"BF02904687_CR3","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V83.6.1612.1612","volume":"83","author":"PC Bruin de","year":"1994","unstructured":"de Bruin PC, Jiwa M, Oudejans JJ, et al: Presence of Epstein Barr virus in extranodal T- cell lymphomaas. Differences in relation to site. Blood 83:1612\u20131618, 1994.","journal-title":"Blood"},{"key":"BF02904687_CR4","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/1097-0142(19830515)51:10<1777::AID-CNCR2820511003>3.0.CO;2-E","volume":"51","author":"DP Burkitt","year":"1983","unstructured":"Burkitt DP: The discovery of Burkitts Lymphoma. Cancer 51:1777\u20131786, 1983.","journal-title":"Cancer"},{"key":"BF02904687_CR5","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1128\/JVI.69.6.3752-3758.1995","volume":"69","author":"F Chen","year":"1995","unstructured":"Chen F, Zou JZ, di Renzo L, et al: A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP-1. J Virology 69:3752\u20133758, 1995.","journal-title":"J Virology"},{"key":"BF02904687_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0065-230X(08)60436-4","volume":"50","author":"J Dillner","year":"1988","unstructured":"Dillner J and Kallin B: The Epstein-Barr virus proteins. (Review) Adv in Cancer Research 50:95\u2013158, 1988.","journal-title":"(Review) Adv in Cancer Research"},{"key":"BF02904687_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0966-842X(00)88891-5","volume":"3","author":"PJ Farell","year":"1995","unstructured":"Farell PJ: Epstein-Barr virus immortalizing genes. (Review) Trends in Microbiol 3:105\u2013109, 1995.","journal-title":"(Review) Trends in Microbiol"},{"key":"BF02904687_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0065-230X(08)60712-5","volume":"67","author":"G Gaidano","year":"1995","unstructured":"Gaidano G and Dalla-Favera R: Molecular pathogenesis of AIDS- related lymphomas. Adv Cancer Res 67:113\u2013153, 1995.","journal-title":"Adv Cancer Res"},{"key":"BF02904687_CR9","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1093\/emboj\/16.20.6131","volume":"16","author":"O Gires","year":"1997","unstructured":"Gires O, Zimber-Strobl U. Gonella R, Ueffing M, et al: Latent membrane protein 1 of Epstein-Barr virus mimics a constitutive active receptor molecule. EMBO J. 16:6131\u20136140, 1997.","journal-title":"EMBO J."},{"key":"BF02904687_CR10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","volume":"71","author":"CD Gregory","year":"1990","unstructured":"Gregory CD, Rowe M and Rickinson AB: Different EpsteinBarr virus- B cell interaction in phenotypically distinct clones of a Burkitts lymphoma cell line. J Gen Virol 71:1481\u20131495, 1990.","journal-title":"J Gen Virol"},{"key":"BF02904687_CR11","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","volume":"65","author":"S Henderson","year":"1991","unstructured":"Henderson S, Rowe M, Gregory C, et al: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107\u20131115, 1991.","journal-title":"Cell"},{"key":"BF02904687_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-642-67236-1_13","volume-title":"The Epstein-Barr Virus","author":"W Henle","year":"1979","unstructured":"Henle W and Henle G: The virus as the etiologic agent of infectious mononucleosis. In: The Epstein-Barr Virus. (Eds: Epstein MA and Achong BG), Berlin, Springer Verlag, 297\u2013320, 1979."},{"key":"BF02904687_CR13","first-page":"13","volume":"137","author":"H Herbst","year":"1990","unstructured":"Herbst H, Niedobitek G, Kneba M, et al: High incidence of Epstein-Barr virus genomes in Hodgkins disease. Am J Pathol 137:13\u201318, 1990.","journal-title":"Am J Pathol"},{"key":"BF02904687_CR14","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","volume":"91","author":"S Imai","year":"1994","unstructured":"Imai S, Koizumi S, Sugiura M, et al: Gastric carcinoma: monoclonal epithelial malignant cell expressing Epstein- Barr virus latent infection protein. Proc Nat Acad Sci 91:9131\u20139135, 1994.","journal-title":"Proc Nat Acad Sci"},{"key":"BF02904687_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0092-8674(89)90394-2","volume":"58","author":"G Klein","year":"1989","unstructured":"Klein G: Viral latency and transfromation: the strategy of Epstein- Barr virus. Cell 58:5\u20138, 1989.","journal-title":"Cell"},{"key":"BF02904687_CR16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(94)90125-2","volume":"77","author":"G Klein","year":"1994","unstructured":"Klein G: Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791\u2013793, 1994.","journal-title":"Cell"},{"key":"BF02904687_CR17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","volume":"375","author":"J Levitskaya","year":"1995","unstructured":"Levitskaya J, Coram M, Levitsky V, et al: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685\u2013688, 1995.","journal-title":"Nature"},{"key":"BF02904687_CR18","first-page":"133","volume-title":"Adv Cancer Res","author":"I Magrath","year":"1990","unstructured":"Magrath I: The pathogenesis of Burkitt lymphoma. In Adv Cancer Res (ed Vande Woude GF and Klein G) 133\u2013269. San Diego: Acad. Press Inc. 1990."},{"key":"BF02904687_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0966-842X(94)90599-1","volume":"2","author":"MG Masucci","year":"1994","unstructured":"Masucci MG and Ernberg I: Epstein-Barr virus: adaptation in a life within the immune system.Trends of Microbiol 2:125\u2013130, 1994.","journal-title":"Trends of Microbiol"},{"key":"BF02904687_CR20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ijc.2910220604","volume":"22","author":"DJ Moss","year":"1978","unstructured":"Moss DJ, Rickinson AB and Pope JH: Long term T-cell -mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus induced transfromation in cultures of seropositive donor leukocytes. Intern J Cancer 22:662\u2013668, 1978.","journal-title":"Intern J Cancer"},{"key":"BF02904687_CR21","first-page":"149","volume-title":"(Review) Important Advances in Oncology","author":"RJ OReilly","year":"1966","unstructured":"OReilly RJ, Lacerda JF, Lucas KG, et al: Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants. (Review) Important Advances in Oncology (Ed: DeVita VT, Hellman S and Rosenberg S) Lippincott-Raven, Philadelphia: 149\u2013166, 1966.","edition":"et al"},{"key":"BF02904687_CR22","first-page":"179","volume":"62","author":"G Pallesen","year":"1993","unstructured":"Pallesen G, Hamilton-Dutoit SJ and Zhou X: The association of Epstein-Barr virus (EBV) with T cell lymphoproliferation and Hodgkin\u2019s disease: two new developments in the EBV field. In: Adv Cancer Research 62:179\u2013239, 1993.","journal-title":"In: Adv Cancer Research"},{"key":"BF02904687_CR23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0952-7915(96)80036-7","volume":"8","author":"AB Rickinson","year":"1996","unstructured":"Rickinson AB, Lee SP and Steven NM: Cytotoxic T-lymphocyte response to Epstein-Barr virus (Review) Current Opinion in Immunology 8:492\u2013497, 1996.","journal-title":"(Review) Current Opinion in Immunology"},{"key":"BF02904687_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1040-8428(97)00008-5","volume":"26","author":"IJ Su","year":"1997","unstructured":"Su IJ, Chen JY: The role of Epstein-Barr virus in lymphoid malignancies. Critical Rev in Oncology\/Hematology 26:25\u201341, 1997.","journal-title":"Critical Rev in Oncology\/Hematology"},{"key":"BF02904687_CR25","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JVI.64.5.2309-2318.1990","volume":"64","author":"F Wang","year":"1990","unstructured":"Wang F, Gregory C, Sample C, et al: Epstein-Barr virus latent membrane protein (LMP-1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B-lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 64:2309\u20132318, 1990.","journal-title":"J Virol"},{"key":"BF02904687_CR26","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1128\/JVI.71.7.5688-5691.1997","volume":"71","author":"H Yoshiyama","year":"1997","unstructured":"Yoshiyama H,Imai S,Shimizu N, et al: Epstein Barr virus infection of human gastric carcinoma cells: Implication of the existence of a new virus receptor different from CD21. J Virol 71:5088\u20135091, 1997.","journal-title":"J Virol"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02904687.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02904687\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02904687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T14:39:40Z","timestamp":1589467180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02904687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["BF02904687"],"URL":"https:\/\/doi.org\/10.1007\/bf02904687","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}